ARTICLE SUMMARY:
Despite the availability of more than two dozen anticonvulsant drugs, one-third of epilepsy patients still have seizures. When drugs fail, Precisis, the developer of a minimally invasive brain stimulation device, aims to offer the very next treatment. Its EASEE platform recently received CE mark approval, making the device available to adult patients with epilepsy in the EU.
Living with epilepsy can be challenging. The ever-present risk of seizures, which might cause patients to lose physical control or even fall, precludes many activities and careers they would otherwise love to engage in. Patients are advised to “seizure-proof” their homes. Many fear the social stigma of their disease and become isolated. Some types of seizures place patients at risk of sudden and unexpected death. It’s easy to understand why anxiety and depression are frequent comorbidities of epilepsy.
